Progressive multifocal leukoencephalopathy after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma treated with combination therapy
- 22 July 2016
- journal article
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 368, 304-306
- https://doi.org/10.1016/j.jns.2016.07.045
Abstract
No abstract availableFunding Information
- Smoking Research Foundation
- JSPS (16H05279)
- JSPS (26461286)
- Ministry of Health, Labour and Welfare
- Japan Agency for Medical Research and Development (AMED)
This publication has 7 references indexed in Scilit:
- Progressive multifocal leukoencephalopathy: current treatment options and future perspectivesTherapeutic Advances in Neurological Disorders, 2015
- Immune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk FactorsFrontiers in Immunology, 2015
- Sorting out the risks in progressive multifocal leukoencephalopathyNature Reviews Rheumatology, 2014
- Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in JapanBMC Neurology, 2012
- Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment optionCase Reports, 2011
- Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapyBone Marrow Transplantation, 2010
- The role of natalizumab in hematopoietic stem cell mobilizationExpert Opinion on Biological Therapy, 2009